ANGLE to collaborate with Abbott Laboratories on metastatic breast cancer study

02:38 EST 6 Feb 2018 | Proactive Investors

Abbott will provide its proprietary PathVysion HER-2 DNA FISH Probe kits for ANGLE's ANG-002 FDA study for FISH analysis of circulating tumour cells in the form of a research grant

Original Article: ANGLE to collaborate with Abbott Laboratories on metastatic breast cancer study

NEXT ARTICLE

More From BioPortfolio on "ANGLE to collaborate with Abbott Laboratories on metastatic breast cancer study"